Background: Exposures associated with mpox infection remain imperfectly understood.
Methods: We conducted a case-control study enrolling participants who received molecular tests for mpox/orthopoxvirus in California from November 2022 through June 2023. We collected data on behaviors during a 21-day risk period before symptom onset or testing among mpox case patients and test-negative controls.
Objective: Infants and children under 5-years are at an increased risk of complications from influenza. We aimed to evaluate characteristics associated with uptake of Australian state and territory funded influenza vaccine programs in 2018 for children aged 6-months to 5-years.
Materials And Methods: A national online survey of 1002 Australian parents with at least one child aged between 6-months and 5-years (response rate 29.